[HTML][HTML] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

T Yamamoto, S Umegae… - World Journal of …, 2006 - ncbi.nlm.nih.gov
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.

T Yamamoto, S Umegae… - World Journal of …, 2006 - europepmc.org
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

[PDF][PDF] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

T Yamamoto, S Umegae, K Matsumoto - World J Gastroenterol, 2006 - researchgate.net
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

[引用][C] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

T YAMAMOTO - World J Gastroenterol, 2006 - cir.nii.ac.jp
Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for
ulcerative colitis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

T Yamamoto, S Umegae… - World journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

[HTML][HTML] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

K Matsumoto, S Umegae, T Yamamoto - World Journal of …, 2006 - wjgnet.com
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

[PDF][PDF] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

T Yamamoto, S Umegae, K Matsumoto - World J Gastroenterol, 2006 - Citeseer
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

[PDF][PDF] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

T Yamamoto, S Umegae, K Matsumoto - World J Gastroenterol, 2006 - researchgate.net
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

[引用][C] Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

T Yamamoto, S Umegae, K Matsumoto - World Journal of …, 2006 - wjgnet.com
Figure 1 An outline of GMCAP procedures using the Adacolumn. Blood is drawn into the
column from the antecubital vein of one hand, and returned to the patient via antecubital …

Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.

T Yamamoto, S Umegae… - World Journal of …, 2006 - europepmc.org
Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …